These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen. Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892 [No Abstract] [Full Text] [Related]
4. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection. Kleine-Tebbe J Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448 [No Abstract] [Full Text] [Related]
5. [Specific immunotherapy: indications and contraindications]. Reinhardt MC Rev Med Suisse Romande; 1994 Mar; 114(3):233-43. PubMed ID: 8171233 [No Abstract] [Full Text] [Related]
12. Advantages and disadvantages of accelerated immunotherapy schedules. Cox L J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664 [No Abstract] [Full Text] [Related]
13. Allergen-specific immunotherapy: current concepts and future directions. Bieber T; Simon HU Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373 [No Abstract] [Full Text] [Related]
14. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance. Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063 [No Abstract] [Full Text] [Related]
15. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349 [No Abstract] [Full Text] [Related]
16. What is the factor that improves adherence to allergen-specific immunotherapy? A secretary! Lombardi C Ann Allergy Asthma Immunol; 2015 Jun; 114(6):530-1. PubMed ID: 25863450 [No Abstract] [Full Text] [Related]
19. Rush injection therapy for asthma and allergic rhinitis. Greenberger PA Ann Allergy; 1994 Nov; 73(5):378-80. PubMed ID: 7978528 [No Abstract] [Full Text] [Related]
20. The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group. Allergy; 1989 Aug; 44(6):369-79. PubMed ID: 2679219 [No Abstract] [Full Text] [Related] [Next] [New Search]